This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
Zacks News
Is Chewy's Multi-Segment Approach the Formula for Scalable Growth?
by Swagata Bhattacharya
CHWY's first-quarter surge was powered by Autoship, Vet Care and Chewy+, with every segment contributing to broad-based growth.
Is Hardgoods Chewy's Next Big Growth Engine Beyond Consumables?
by Swagata Bhattacharya
CHWY's Hardgoods rose 12.3% in Q1, as new brands, faster launches, and personalization bolster full-year $12.3B-$12.45B outlook.
Is Autoship the Secret Behind Chewy's Customer Retention Success?
by Swagata Bhattacharya
CHWY's Autoship hits a record 82.2% of sales, fueling customer loyalty and driving its fiscal 2025 growth outlook.
Is Chewy's 6.2% Q1 EBITDA Margin a Turning Point Toward Its Target?
by Swagata Bhattacharya
CHWY's adjusted EBITDA margin improves to 6.2% in Q1 as Autoship and ads lifted results, signaling progress toward 10%.
Chewy Stock Trades at a Discount: Should You Buy or Hold for Now?
by Swagata Bhattacharya
CHWY's growth accelerates with stronger Autoship sales, rising customer retention and expanding vet care services.
Can Chewy Maintain Its Momentum in Active Customer Growth?
by Swagata Bhattacharya
CHWY's active customers hit 20.8M in Q1, driven by lower churn, stronger reorders and rising Chewy+ adoption.
Should You Buy, Hold or Sell Chewy Stock Before Q1 Earnings?
by Swagata Bhattacharya
CHWY eyes Q1 y/y revenue and earnings growth as Autoship, ads and vet services fuel its diversified pet care strategy.
Petco Health & Wellness (WOOF) Reports Q1 Loss, Misses Revenue Estimates
by Zacks Equity Research
Petco (WOOF) delivered earnings and revenue surprises of 50% and 0.01%, respectively, for the quarter ended April 2025. Do the numbers hold clues to what lies ahead for the stock?
Five Below (FIVE) Q1 Earnings and Revenues Surpass Estimates
by Zacks Equity Research
Five Below (FIVE) delivered earnings and revenue surprises of 3.61% and 0.31%, respectively, for the quarter ended April 2025. Do the numbers hold clues to what lies ahead for the stock?
Build-A-Bear (BBW) Tops Q1 Earnings and Revenue Estimates
by Zacks Equity Research
Build-A-Bear (BBW) delivered earnings and revenue surprises of 36.05% and 8.86%, respectively, for the quarter ended April 2025. Do the numbers hold clues to what lies ahead for the stock?
Here's Why Petco Health & Wellness (WOOF) is a Great Momentum Stock to Buy
by Zacks Equity Research
Does Petco Health & Wellness (WOOF) have what it takes to be a top stock pick for momentum investors? Let's find out.
Despite Fast-paced Momentum, Petco (WOOF) Is Still a Bargain Stock
by Zacks Equity Research
Petco (WOOF) made it through our 'Fast-Paced Momentum at a Bargain' screen and could be a great choice for investors looking for stocks that have gained strong momentum recently but are still trading at reasonable prices.
Arhaus, Inc. (ARHS) Q1 Earnings and Revenues Lag Estimates
by Zacks Equity Research
Arhaus, Inc. (ARHS) delivered earnings and revenue surprises of -50% and 0.55%, respectively, for the quarter ended March 2025. Do the numbers hold clues to what lies ahead for the stock?
Should You Still Buy Chewy Stock After Its 15% Rise in a Month?
by Sumit Singh
Chewy's strong growth, strategic expansions and solid financials make it an attractive investment. Is there more room for growth?
Petco Earnings Miss Estimates in Q4, Comparable Sales Rise Y/Y
by Zacks Equity Research
WOOF's fiscal fourth-quarter results reflect lower y/y sales. However, the gross margin expands 180 bps y/y to 38% in the quarter.
Petco Health & Wellness (WOOF) Reports Break-Even Earnings for Q4
by Zacks Equity Research
Petco (WOOF) delivered earnings and revenue surprises of -100% and 0.02%, respectively, for the quarter ended January 2025. Do the numbers hold clues to what lies ahead for the stock?
Five Below (FIVE) Q4 Earnings and Revenues Beat Estimates
by Zacks Equity Research
Five Below (FIVE) delivered earnings and revenue surprises of 2.96% and 0.87%, respectively, for the quarter ended January 2025. Do the numbers hold clues to what lies ahead for the stock?
Ulta Beauty (ULTA) Q4 Earnings and Revenues Top Estimates
by Zacks Equity Research
Ulta (ULTA) delivered earnings and revenue surprises of 19.15% and 0.69%, respectively, for the quarter ended January 2025. Do the numbers hold clues to what lies ahead for the stock?
Is Chewy Stock Still a Buy After Gaining 16% in the Past 3 Months?
by Sumit Singh
Chewy's impressive rally signals strong growth prospects, but with rising costs and a premium valuation, is it still a smart buy?
Chewy Stock Trading at a Premium: Is the Best Buying Window Over?
by Sumit Singh
Chewy is well-positioned to capitalize on favorable dynamics and internal initiatives. However, rising costs and increased competition remain concerns.
Central Garden & Pet Dips 14% in a Month: Solid Bargain or Risky Bet?
by Zacks Equity Research
Technical breakdowns and declining demand spell trouble for CENT. Can it recover?
What Makes Petco (WOOF) a New Strong Buy Stock
by Zacks Equity Research
Petco (WOOF) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #1 (Strong Buy).
Do Options Traders Know Something About Petco Health (WOOF) Stock We Don't?
by Zacks Equity Research
Investors need to pay close attention to Petco Health (WOOF) stock based on the movements in the options market lately.
Chewy Stock Up 37% YTD: What's the Best Move for Investors Now?
by Sumit Singh
Chewy is well-positioned to capitalize on favorable dynamics and internal initiatives. However, rising costs and increased competition remain concerns.
Is CAVA Group, Inc. (CAVA) Stock Outpacing Its Retail-Wholesale Peers This Year?
by Zacks Equity Research
Here is how Cava Group (CAVA) and Petco Health & Wellness (WOOF) have performed compared to their sector so far this year.